|1.||Silva, Regina H: 8 articles (07/2015 - 05/2002)|
|2.||Abílio, Vanessa C: 7 articles (09/2013 - 05/2002)|
|3.||Singh, Amanpreet: 6 articles (02/2006 - 06/2003)|
|4.||Naidu, Pattipati S: 6 articles (02/2006 - 06/2003)|
|5.||Kulkarni, Shrinivas K: 6 articles (02/2006 - 06/2003)|
|6.||Frussa-Filho, Roberto: 6 articles (06/2005 - 05/2002)|
|7.||Fachinetto, Roselei: 5 articles (10/2013 - 12/2004)|
|8.||Rocha, João B T: 5 articles (04/2009 - 02/2003)|
|9.||Ribeiro, Alessandra M: 4 articles (07/2015 - 08/2008)|
|10.||Reckziegel, Patrícia: 4 articles (10/2013 - 04/2009)|
|1.||Hypertension (High Blood Pressure)
01/01/2009 - "Blood pressure lowering efficacy of reserpine for primary hypertension."
09/01/1997 - "Low-dose reserpine/thiazide combination in first-line treatment of hypertension: efficacy and safety compared to an ACE inhibitor."
02/01/1997 - "Thus, the use of this low-dose reserpine-thiazide combination appears to be a rational alternative to conventional monotherapy in the first-line treatment of hypertension."
10/01/1967 - "[On the efficacy of reserpine in hypertension of the lesser circulation]."
01/01/2009 - "Included studies were truly randomised controlled trials comparing reserpine monotherapy to placebo or no treatment in patients with primary hypertension. "
|2.||Movement Disorders (Movement Disorder)
01/01/2012 - "The present study concludes that the oxidative stress might play an important role in reserpine-induced abnormal oral movements, and Murraya koenigii may have great potential in the treatment of neuroleptic-induced orofacial dyskinesia. "
01/01/2012 - "In this study, the neuroprotective potential and in vivo antioxidant status of extract of roots and rhizomes of Rubia cordifolia L (MERC) in reserpine-induced orofacial dyskinesia was studied. "
04/01/2011 - "In the present study, reserpine (1 mg kg(-1), s.c.) was given to rats on days 1, 3 and 5 to induce orofacial dyskinesia, which is characterised by increased vacuous chewing and tongue protrusion. "
07/01/2009 - "The results of the present study suggested that Hibiscus rosa sinensis had a protective role against reserpine-induced orofacial dyskinesia and oxidative stress."
05/14/2002 - "The aim of the present study was to investigate the effects of reserpine administration on the development of orofacial dyskinesia and on plus-maze discriminative avoidance task (DAT-an animal model of associative learning) in male and female mice. "
|3.||Parkinson Disease (Parkinson's Disease)
07/01/2007 - "Furthermore, we apply the method to study the changes of endogenous peptide levels in mouse brain striatum after administration of reserpine, a classical model drug for inducing Parkinson disease symptoms."
07/01/2015 - "The administration of reserpine to rodents was one of the first models used to investigate the pathophysiology and screening for potential treatments of Parkinson's disease (PD). "
07/01/2015 - "Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long-Standing Model."
08/21/2013 - "In contrast, reserpine (20 and 40 mg/L) did not evoke overt acute behavioral effects, but markedly reduced activity 7 days later, resembling motor retardation observed in depression and/or Parkinson's disease. "
05/16/2012 - "Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease."
06/01/2014 - "Our study provides strong evidence that Gent inhibits reserpine-induced pain/depression dyad by downregulating GluN2B receptors in the amygdala."
03/01/2015 - "Pain may be further amplified by reserpine-induced dysfunction of the descending pain inhibitory system and by the decrease in peripheral drive to this system resulting from a reduced proportion of mechanoresponsive C-nociceptors."
03/01/2015 - "Peripheral and spinal mechanisms of nociception in a rat reserpine-induced pain model."
06/01/2014 - "Systemic Gent administration dose-dependently ameliorated the behavioral deficits associated with reserpine-induced pain/depression dyad. "
06/01/2014 - "However, the effects of Gent on the reserpine-induced pain/depression dyad and its underlying mechanisms are unclear. "
06/01/1968 - "Studies on the experimental gastrointestinal ulcers produced by reserpine and stress. "
03/01/1968 - "Studies on the experimental gastrointestinal ulcers produced by reserpine and stress. "
12/01/1967 - "Studies on the experimental gastrointestinal ulcers produced by reserpine and stress. "
07/01/1997 - "Marked antiulcerative properties of a Populus tremula bark extract were demonstrated in experiments on mice and rats with stress-, reserpine-induced, and acetylsalicylic ulcers. "
09/01/1993 - "The authors' data provide evidence that reserpine is not associated with ulcer disease in elderly persons and suggest that a history of ulcer disease need not be a contraindication to the use of this drug."
|1.||Serotonin (5 Hydroxytryptamine)
|4.||Levodopa (L Dopa)
|9.||Adrenocorticotropic Hormone (ACTH)
|5.||Vagus Nerve Stimulation